For research use only. Not for therapeutic Use.
SARS-CoV-IN-1(Cat No.:I016220)is a potent inhibitor of the SARS-CoV-2 virus, targeting its main protease (Mpro) and interfering with viral replication. It effectively binds to the active site of the enzyme, preventing the cleavage of polyproteins into functional viral proteins, which is essential for the virus’s replication cycle. This compound shows promise as a therapeutic candidate in the fight against COVID-19 by disrupting key viral processes. Research indicates its potential for use in antiviral drug development, offering a novel approach to inhibiting SARS-CoV-2 replication.
Catalog Number | I016220 |
CAS Number | 888958-25-6 |
Molecular Formula | C₂₃H₁₆ClFeN₃O |
Purity | ≥95% |
Target | SARS-CoV |
Reference | [1]. Biot C, et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006 May 4;49(9):2845-9. |